drugset / Trial / NCT05718466

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

NCT05718466

Phase 3 Completed 35 enrolled Henry Ford Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial is a prospective study of radiosurgery treatment for progressive GBM to test 1)the efficacy of radiosurgery for recurrent/progressive GBM compared to chemotherapy , and 2) the role of diffusion-weighted image (DWI) to predict the early tumor progression and treatment response.

Timeline

Start
2010-11
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Background Bevacizumab Monoclonal antibody
Background Carboplatin Small molecule
Background Etoposide Small molecule
Background Irinotecan Small molecule
Background Temozolomide Small molecule

Indications